✦ LIBER ✦
4019 POSTER Phase III, randomized, open-label study of triweekly docetaxel (tT) vs. biweekly docetaxel (bT) as treatment for advanced hormone refractory prostate cancer (HRPC): findings from an interim safety analysis
✍ Scribed by P. Kellokumpu-Lehtinen; T. Joensuu; P. Hervonen; P. Nyandoto; T. Luukkaala; A. Hemminki; R. Asola; M. Luukkaa; I. Lehtinen; H. Joensuu
- Book ID
- 118625929
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 59 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.